BlackRock Group’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.32M Sell
346,511
-6,444
-2% -$46.8K ﹤0.01% 2000
2016
Q3
$3.16M Buy
352,955
+17,891
+5% +$150K ﹤0.01% 1336
2016
Q2
$2.36M Buy
335,064
+13,766
+4% +$126K ﹤0.01% 1457
2016
Q1
$2.73M Buy
321,298
+17,397
+6% +$171K ﹤0.01% 1356
2015
Q4
$3.99M Sell
303,901
-32,880
-10% -$295K ﹤0.01% 1175
2015
Q3
$1.23M Sell
336,781
-121,728
-27% -$595K ﹤0.01% 1762
2015
Q2
$2.64M Sell
458,509
-92,511
-17% -$535K ﹤0.01% 1410
2015
Q1
$3.22M Sell
551,020
-94,691
-15% -$653K ﹤0.01% 1283
2014
Q4
$5.06M Buy
+645,711
New +$4.13M ﹤0.01% 1123
2013
Q4
Sell
-13,520
Closed -$75K 2752
2013
Q3
$75K Buy
+13,520
New +$46.9K ﹤0.01% 2651

Other funds holding PACB